| （単位：千ドル） | 1Q21 | 2Q21 | 3Q21 | 1Q22 | 2Q22 | 3Q22 | 1Q23 | 2Q23 | 3Q23 | 1Q24 | 2Q24 | 3Q24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 研究開発費 | 4,400 | 4,900 | 4,100 | 7,121 | 8,900 | 9,400 | 8,530 | 12,500 | 10,488 | 13,170 | 20,445 | 21,450 |
| 営業費用 | 5,703 | 6,987 | 6,355 | 9,620 | 11,567 | 11,884 | 11,962 | 15,642 | 13,582 | 18,110 | 25,643 | 28,124 |
| 営業利益 | -5,703 | -6,987 | -6,355 | -9,620 | -11,567 | -11,884 | -11,962 | -15,642 | -13,582 | -18,110 | -25,643 | -28,124 |
| 純利益 | -5,699 | -6,980 | -6,345 | -9,597 | -11,407 | -11,596 | -11,456 | -14,999 | -12,934 | -14,986 | -21,785 | -24,540 |
| 一株あたり利益 | - | - | - | - | -0.67 | -0.68 | -0.56 | -0.65 | -0.55 | -0.42 | -0.56 | -0.63 |
| 希薄化後一株あたり利益 | - | - | - | - | -0.67 | -0.68 | -0.56 | -0.65 | -0.55 | -0.42 | -0.56 | -0.63 |
| EBITDA | - | - | - | - | - | - | - | - | - |